https://orcid.org/0000-0001-5601-4207
References
- Andrieu, J. M., Lu, W., & Levy, R. (1995). Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. The Journal of Infectious Diseases, 171(3), 523–530. doi: 10.1093/infdis/171.3.523
- Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. (1990). The New England Journal of Medicine, 323(21), 1500–1504. doi.org/10.1056/NEJM199011223232131
- Ewald, H., Raatz, H., Boscacci, R., Furrer, H., Bucher, H. C., & Briel, M. (2015). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. The Cochrane Database of Systematic Reviews, (4), CD006150. doi.org/10.1002/14651858.CD006150.pub2
- Gurwitz, J. H., Bohn, R. L., Glynn, R. J., Monane, M., Mogun, H., & Avorn, J. (1994). Glucocorticoids and the risk for initiation of hypoglycemic therapy. Archives of Internal Medicine, 154(1), 97–101. doi: 10.1001/archinte.1994.00420010131015
- Kasang, C., Kalluvya, S., Majinge, C., Kongola, G., Mlewa, M., Massawe, I., … Scheller, C. (2016). Effects of prednisolone on disease progression in antiretroviral-untreated HIV infection: A 2-year randomized, double-blind placebo-controlled clinical trial. PLoS One, 11(1), e0146678. doi.org/10.1371/journal.pone.0146678
- Kasang, C., Ulmer, A., Donhauser, N., Schmidt, B., Stich, A., Klinker, H., … Scheller, C. (2012). HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients. BMC Infectious Diseases, 12, 14. doi.org/10.1186/1471-2334-12-14
- Kaufmann, G. R., Furrer, H., Ledergerber, B., Perrin, L., Opravil, M., Vernazza, P., … Battegay, M. (2005). Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 41(3), 361–372. doi.org/10.1086/431484
- Kilby, J. M., Tabereaux, P. B., Mulanovich, V., Shaw, G. M., Bucy, R. P., & Saag, M. S. (1997). Effects of tapering doses of oral prednisone on viral load among HIV-infected patients with unexplained weight loss. AIDS Research and Human Retroviruses, 13(17), 1533–1537. doi.org/10.1089/aid.1997.13.1533
- McComsey, G. A., Whalen, C. C., Mawhorter, S. D., Asaad, R., Valdez, H., Patki, A. H., … Lederman, M. M. (2001). Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS (London, England), 15(3), 321–327. doi: 10.1097/00002030-200102160-00004
- Notermans, D. W., Pakker, N. G., Hamann, D., Foudraine, N. A., Kauffmann, R. H., Meenhorst, P. L., … Danner, S. A. (1999). Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. The Journal of Infectious Diseases, 180(4), 1050–1056. doi.org/10.1086/315013
- Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., … Sorrell, T. C. (2010). Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 50(3), 291–322. doi.org/10.1086/649858
- Stuck, A. E., Minder, C. E., & Frey, F. J. (1989). Risk of infectious complications in patients taking glucocorticosteroids. Reviews of Infectious Diseases, 11(6), 954–963. doi: 10.1093/clinids/11.6.954
- Thwaites, G. E., Nguyen, D. B., Nguyen, H. D., Hoang, T. Q., Do, T. T. O., Nguyen, T. C. T., … Farrar, J. J. (2004). Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. The New England Journal of Medicine, 351(17), 1741–1751. doi.org/10.1056/NEJMoa040573
- van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2002). The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 13(10), 777–787. doi.org/10.1007/s001980200108
- Verbruggen, G., Herman, L., Ackerman, C., Mielants, H., & Veys, E. M. (1987). The effect of low doses of prednisolone on T-cell subsets in rheumatoid arthritis. International Journal of Immunopharmacology, 9(1), 61–67. doi: 10.1016/0192-0561(87)90111-1
- Wallis, R. S. (2007). Corticosteroids and HIV infection: A review of experience. Current Opinion in HIV and AIDS, 2(3), 213–218. doi.org/10.1097/COH.0b013e3280eec766
- Wallis, R. S., Kalayjian, R., Jacobson, J. M., Fox, L., Purdue, L., Shikuma, C. M., … Lederman, M. M. (2003). A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3). Journal of Acquired Immune Deficiency Syndromes, 32(3), 281–286. doi: 10.1097/00126334-200303010-00006
- Zweiman, B., Atkins, P. C., Bedard, P. M., Flaschen, S. L., & Lisak, R. P. (1984). Corticosteroid effects on circulating lymphocyte subset levels in normal humans. Journal of Clinical Immunology, 4(2), 151–155. doi: 10.1007/BF00915049
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112442/MPU-social-sciences.png"})